- Biofarm registers a turnover of lei 239 million in 2021, up by 10% compared to 2020
- The net profit increased by 11%, to 60 million lei
- EBITDA reached 82 million lei, an increase of 10% compared to 2020
- In the CHC segment, Biofarm is second place in volume terms
- Biofen Extra, the latest brand release from the Biofarm portfolio, becomes the value leader in the ibuprofen and paracetamol combination segment, within the first eight months of its launch
If you want to read the entire content, you
need a subscription to Nine O’Clock
This content is for subscriber members only.
Subscribe now
Only 59 euros / month or 400 euros / year (VAT not included)
Get access to:
120.000 articles in 32 years of Nine O`Clock
600 new articles every month
No ads experience on the website
Do you already have an subscriber account? Enter in your account here: Login
The diplomatic daily newspaper Nine O’Clock does not assume responsibility for the information received and published on the public website. The responsibility for the content lies solely with the issuer of the press release. The diplomatic daily newspaper Nine O’Clock cannot be held accountable for false information transmitted by the…
If you want to read the entire content, you
need a subscription to Nine O’Clock
This content is for subscriber members only.
Subscribe now
Only 59 euros / month or 400 euros / year (VAT not included)
Get access to:
120.000 articles in 32 years of Nine O`Clock
600 new articles every month
No ads experience on the website
Do you already have an subscriber account? Enter in your account here: Login
